New NHS Weight Loss Injection (Mounjaro) – Limited Launch
We are taking part in a new NHS programme offering the Mounjaro weight loss injection, designed to help people with obesity and related health conditions. The programme is being introduced in stages (called “cohorts”) between 2025 and 2028.

⚠️ Please do not contact the surgery about this programme.
We will reach out directly to eligible patients. Only a very limited number of patients can be invited at this stage.

Cohort 1: 2025–2026
In the first stage, we are allowed to invite just 10 patients who meet strict medical criteria.

To be eligible for Cohort 1, you must:

Have a BMI of 40 or above
(or 37.5 or above if you are from a South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean background)
AND

Have 4 out of the 5 obesity-related health conditions listed below.

Obesity-related conditions:
Cardiovascular disease – e.g. heart failure, stroke, heart disease, or peripheral vascular disease

High blood pressure (hypertension) – requiring medication

High cholesterol – being treated with medication

Obstructive sleep apnoea – confirmed by a sleep study and requiring a CPAP machine

Type 2 diabetes

Future Phases
We know many patients are interested. The NHS will gradually expand the programme over the next few years:

Cohort 2: 2026–2027
BMI between 35–39.9
(or 32.5–37.4 for the above ethnic backgrounds)
AND

4 out of the 5 obesity-related conditions listed above

Cohort 3: 2027–2028
BMI of 40 or above
(or 37.5 or above for the above ethnic backgrounds)
AND

3 out of the 5 conditions listed above

What You Need to Do
✅ Nothing right now.
We will contact you if you meet the criteria.
Please do not call the surgery — we understand the interest, but access is currently very limited.

Thank you for your patience and understanding.